Best Cannabis & Marijuana Stocks

Best cannabis & marijuana stocks for 2023. Cannabis is a plant that can be used to treat, manage, or improve medical symptoms. It is also used for recreational purposes, given its psychoactive properties. Also known as marijuana, weed, and other names, it has become legal or decriminalized in most U.S. states, Canada, and other places. Consumers are becoming more accepting of cannabis, appreciating its medicinal and recreational properties. This has led to a slew of companies that research, develop, and distribute medical and recreational marijuana. As a result, the marijuana industry is projected to double in value by 2025, making it popular with investors. This list covers the best cannabis companies.

Compare up to 10 stocks

Cannabis Stocks

Comparison Ideas 5g Stocks AAPL vs. MSFT (Apple vs. Microsoft)AAPL vs. NVDA (Apple vs. Nvidia)Adtech Stocks Aerospace and Defense Stocks Airline Stocks AMD vs. INTC (AMD vs. Intel)AMZN vs. GOOGL AMZN vs. WMT (Amazon vs. Walmart)Artificial Intelligence Stocks AVGO vs. QCOM (Broadcom vs. Qualcomm)Bank Stocks Batmmaan Stocks Beer & Beverage Stocks Biotech & Longevity Plays Biotech Stocks Bitcoin Stocks Blockchain Stocks Blue Chip Stocks Cannabis Stocks Casino Stocks ChatGPT Stocks Chinese Stocks Chip Stocks Cloud & Storage Stocks COST vs. WMT (Costco vs. Walmart)Cryptocurrency Stocks Cybersecurity Stocks Dividend Stocks Electric Vehicle Stocks Energy Stocks F vs. GM (Ford vs. General Motors)FAANG Stocks Gold Stocks GOOGL vs. META (Alphabet vs. Meta)Green Energy Stocks Green Hydrogen Stocks Growth Stocks HD vs. LOW (Home Depot vs. Lowe's)Healthcare Stocks Highest PE Ratio Stocks Hotel Stocks International Value Diversifiers Stocks Japanese Stocks JPM vs. BAC (JPMorgan vs. Bank of America)KO vs. PEP (Coca-Cola vs. PepsiCo Large Cap Stocks Lowest P/E Ratio Stocks Magnificent 7 Stocks Mega Cap Stocks Meme Stocks Metaverse Stocks MSFT vs. GOOGL vs. AMZN (Cloud Wars)Nuclear Energy Revival Stock Nuclear Stocks NVDA vs. AMD vs. INTC (Chip Giants)NVDA vs. TSM (Nvidia vs. Taiwan Semi)Oil Stocks Onshoring & Rare Earths Supply Stocks OpenAI Stocks Popular BDC Stocks Private Credit & Fintech Risers PYPL vs. XYZ (PayPal vs. Block)Quantum Computing Innovators Stocks Quantum Computing Stocks Robotics & Autonomous Systems Stocks Social Media Stocks Solar Stocks Tech Stocks Top Silver Stocks Trump Tariffs: Stocks at Risk in 2025 Trump Tariffs: Stocks That Could Benefit in 2025 TSLA vs. F vs. GM (Auto Wars)TSLA vs. LCID (Tesla vs. Lucid)TSLA vs. RIVN (Tesla vs. Rivian)Utility Stocks V vs. MA (Visa vs. Mastercard)V vs. MA vs. AXP (Credit Cards)Value Stocks Venezuela Oil Recovery (Energy & Services)Venezuela Seized Assets (Consumer/Industrial)Virtual Reality Stocks WallStreetBets Stocks

RESET ALL

CGC

ABBV

SMG

JAZZ

HEXO

CURLF

GTBIF

TCNNF

Cannabis Stocks

Clear All

Compared Stocks: 9 / 10

Comparison Results

Name	Sector	Price	Volume	Market Cap	P/E Ratio	Dividend Yield	Analyst Consensus	Analyst Price Target
CGC	Healthcare	$1.15	17.96M	$438.39M	―	―	Hold	xxxxxxxxxxxxx
MO	Consumer Defensive	$61.15	14.21M	$103.67B	11.78	6.80%	Moderate Buy	xxxxxxxxxxxxx
ABBV	Healthcare	$214.04	8.25M	$378.84B	161.74	3.11%	Moderate Buy	xxxxxxxxxxxxx
SMG	Basic Materials	$62.80	713.82K	$3.69B	25.71	4.20%	Strong Buy	xxxxxxxxxxxxx
JAZZ	Healthcare	$167.88	840.28K	$10.29B	-27.66	―	Strong Buy	xxxxxxxxxxxxx
CURLF	Healthcare	$2.48	661.03K	$2.02B	-7.12	―	Strong Buy	xxxxxxxxxxxxx
GTBIF	Healthcare	$7.81	471.26K	$1.87B	42.19	―	Moderate Buy	xxxxxxxxxxxxx
TCNNF	Healthcare	$8.08	334.40K	$1.60B	-11.56	―	Strong Buy	xxxxxxxxxxxxx
HEXO	―	―	―	―	―	―	―	xxxxxxxxxxxxx

Popular Stocks Pairs

AAPL vs. MSFT (Apple vs. Microsoft)AAPL vs. NVDA (Apple vs. Nvidia)AMD vs. INTC (AMD vs. Intel)AMZN vs. GOOGL AMZN vs. WMT (Amazon vs. Walmart)AVGO vs. QCOM (Broadcom vs. Qualcomm)COST vs. WMT (Costco vs. Walmart)F vs. GM (Ford vs. General Motors)GOOGL vs. META (Alphabet vs. Meta)HD vs. LOW (Home Depot vs. Lowe's)JPM vs. BAC (JPMorgan vs. Bank of America)KO vs. PEP (Coca-Cola vs. PepsiCo MSFT vs. GOOGL vs. AMZN (Cloud Wars)NVDA vs. AMD vs. INTC (Chip Giants)NVDA vs. TSM (Nvidia vs. Taiwan Semi)

Top 10 Popular Investment Themes

Quantum Computing Stocks Dividend Stocks Magnificent 7 Stocks Nuclear Stocks Oil Stocks Tech Stocks Blue Chip Stocks Energy Stocks Bank Stocks Gold Stocks

Performance Comparison

CGC

Canopy Growth

1.15

-1.08

-48.43%

Altria Group

61.15

13.12

27.32%

ABBV

AbbVie

214.04

47.03

28.16%

SMG

Scotts Miracle-Gro Company

62.80

-5.15

-7.58%

JAZZ

Jazz Pharmaceuticals

167.88

46.45

38.25%

HEXO

―

CURLF

Curaleaf Holdings

2.48

0.99

66.44%

GTBIF

Green Thumb Industries

7.81

0.40

5.40%

TCNNF

Trulieve Cannabis

8.08

3.15

63.89%

Cannabis Latest News

Compare up to 10 stocks

Cannabis Stocks

RESET ALL

CGC

ABBV

SMG

JAZZ

HEXO

CURLF

GTBIF

TCNNF

Cannabis Stocks

Clear All

Compared Stocks: 9 / 10

Scotts Miracle-Gro: Improving Margins and Sentiment Offset by Valuation and Seasonal Demand Risk Justify Hold Rating

Analyst Peter Grom from UBS maintained a Hold rating on Scotts Miracle-Gro Company and keeping the price target at $66.00. Peter Grom has given his Hold rating due to a

3h ago

SMG

Curaleaf Posts Solid Q4 Growth, Exits Hemp Business and Missouri Market

Curaleaf Holdings ( ($TSE:CURA) ) just unveiled an announcement. Curaleaf reported preliminary unaudited fourth-quarter 2025 net revenue of at least $330 million, representing about 4% sequential growth and 1% year-over-year

24h ago

Curaleaf sees Q4 revenue $330M vs. $327.8M last year

Q4 net revenue excluding the discontinued businesses is expected to be at least $330M, implying approximately 4% sequential growth compared to Q3 2025 net revenue of $317.8M, above the previous

1d ago

Curaleaf discontinuing hemp business, exiting Missouri

The company has decided to discontinue its hemp division due to recent federal legislation passed in November 2025 reducing the allowable amount of THC to a non-intoxicating level, and cease

1d ago

AbbVie price target raised to $275 from $270 at Berenberg

Berenberg raised the firm’s price target on AbbVie (ABBV) to $275 from $270 and keeps a Buy rating on the shares. The firm upped its forecasts for AbbVie’s Skyrizi and

1d ago

ABBV

Looking for Exposure to Johnson & Johnson Stock (JNJ) ahead of Q4 Earnings? Here’s How to Buy Without the Risk

Johnson & Johnson ($JNJ) is set to report its Q4 earnings on January 21. Analysts expect revenue of about $24.16 billion, up 7.3% year‑over‑year, and earnings of $2.49 per share, reflecting a

2d ago

BMY

IHE

AbbVie announces results for epcoritamab from Phase 3 EPCORE DLBCL-1 trial

AbbVie (ABBV) announced topline results from the Phase 3 EPCORE DLBCL-1 trial evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, compared to investigator’s choice of chemoimmunotherapy in adult patients

5d ago

ABBV

GMAB

Genmab says OS in Phase 3 trial did not reach statistical significance

Genmab (GMAB) announced results from the Phase 3 EPCORE DLBCL-1 trial evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, which demonstrated an improvement in progression-free survival in patients treated

5d ago

ABBV

GMAB

Midday Fly By: PNC reports Q4 beat, Regions reports quarterly miss

The major averages were mostly unchanged near noon following yesterday’s rally as the S&P 500 reaches for 7,000. Bank earnings have had a mixed week, and strength in semiconductors hasn’t

5d ago

CEG

AbbVie Expands Oncology Pipeline With First-in-Human ABBV-711 Trial in Advanced Squamous Tumors

Abbvie ($ABBV) announced an update on their ongoing clinical study. Study Overview: AbbVie is running a phase 1, first-in-human trial (NCT07241039) titled “A Phase 1 First-in-Human, Open-Label Study Evaluating the

5d ago

ABBV

Read the latest stock news and analysis from the TipRanks news team.

See All News >

Recent Analysts Ratings of Cannabis Stocks

ABBV

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2026-01-21

JAZZ

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2026-01-20

SMG

xxxxxxxxxxxxx

Hold

xxxxxxxxxxxxx

Reiterated

2026-01-20

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2026-01-19

CGC

xxxxxxxxxxxxx

Hold

xxxxxxxxxxxxx

Reiterated

2026-01-14

TCNNF

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2025-12-22

CURLF

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2025-12-22

GTBIF

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2025-11-06

ABBV

xxxxxxxxxxxxx

Hold

xxxxxxxxxxxxx

Reiterated

2026-01-20

ABBV

xxxxxxxxxxxxx

Buy

xxxxxxxxxxxxx

Reiterated

2026-01-20

All Ratings >

Most Recent Earnings of Cannabis Stocks

CGC

Feb 6, 2026TBA

$438.39M

-$0.04

$51.00M

0.89

―

Jan 29, 2026Before Open

$103.67B

$1.32

$5.02B

―

11.78

ABBV

Feb 4, 2026Before Open

$378.84B

$3.19

$16.39B

-6.79

161.74

SMG

Jan 28, 2026Before Open

$3.69B

-$1.01

$356.54M

0.03

25.72

JAZZ

Mar 3, 2026TBA

$10.29B

$6.39

$1.15B

-0.06

-27.66

CURLF

Mar 10, 2026TBA

$2.02B

-$0.08

$326.54M

1.55

-7.12

GTBIF

Mar 3, 2026TBA

$1.87B

$0.02

$295.87M

-0.02

42.19

TCNNF

Feb 26, 2026TBA

$1.60B

-$0.04

$297.47M

0.25

-11.56

Compare Stocks Side-by-SideOur stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.Key Features of Our Stock Comparison

Comprehensive Analysis: Compare up to 10 stocks with detailed metrics including price, market cap, P/E ratio, dividend yield, and more.

Analyst Ratings: View consensus ratings from top Wall Street analysts and their price targets for each stock.

Performance Tracking: Analyze historical performance with interactive charts showing 3-month, 6-month, 1-year, YTD, 3-year, and 5-year returns.

Dividend Information: Evaluate dividend yield, payout ratio, and dividend growth for income-focused investors.

Earnings Data: Compare earnings per share (EPS), revenue growth, and profitability metrics across companies.

How to Use the Stock Comparison ToolSimply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 10 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.

Popular Stock ComparisonsInvestors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).

Why Compare Stocks?Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.

All Stocks Comparison Categories

AAPL vs. MSFT (Apple vs. Microsoft)AMZN vs. GOOGL GOOGL vs. META (Alphabet vs. Meta)AAPL vs. NVDA (Apple vs. Nvidia)AMZN vs. WMT (Amazon vs. Walmart)AMD vs. INTC (AMD vs. Intel)AVGO vs. QCOM (Broadcom vs. Qualcomm)NVDA vs. TSM (Nvidia vs. Taiwan Semi)TSLA vs. RIVN (Tesla vs. Rivian)F vs. GM (Ford vs. General Motors)TSLA vs. LCID (Tesla vs. Lucid)V vs. MA (Visa vs. Mastercard)JPM vs. BAC (JPMorgan vs. Bank of America)PYPL vs. XYZ (PayPal vs. Block)HD vs. LOW (Home Depot vs. Lowe's)KO vs. PEP (Coca-Cola vs. PepsiCo COST vs. WMT (Costco vs. Walmart)NVDA vs. AMD vs. INTC (Chip Giants)MSFT vs. GOOGL vs. AMZN (Cloud Wars)TSLA vs. F vs. GM (Auto Wars)V vs. MA vs. AXP (Credit Cards)Quantum Computing Stocks Dividend Stocks Magnificent 7 Stocks Nuclear Stocks Oil Stocks Tech Stocks Blue Chip Stocks Energy Stocks Bank Stocks Gold Stocks Growth Stocks Bitcoin Stocks Meme Stocks Biotech Stocks Chinese Stocks Artificial Intelligence Stocks Cannabis Stocks Healthcare Stocks Value Stocks Airline Stocks Cybersecurity Stocks OpenAI Stocks Solar Stocks ChatGPT Stocks FAANG Stocks Green Energy Stocks Large Cap Stocks Utility Stocks Chip Stocks Blockchain Stocks Social Media Stocks Cryptocurrency Stocks Electric Vehicle Stocks Japanese Stocks Casino Stocks Metaverse Stocks Highest PE Ratio Stocks Mega Cap Stocks Hotel Stocks Green Hydrogen Stocks 5g Stocks Aerospace and Defense Stocks Batmmaan Stocks WallStreetBets Stocks Virtual Reality Stocks Cloud & Storage Stocks Lowest P/E Ratio Stocks Adtech Stocks Biotech & Longevity Plays Nuclear Energy Revival Stock Onshoring & Rare Earths Supply Stocks Popular BDC Stocks Private Credit & Fintech Risers Quantum Computing Innovators Stocks Robotics & Autonomous Systems Stocks Trump Tariffs: Stocks at Risk in 2025 Trump Tariffs: Stocks That Could Benefit in 2025 Beer & Beverage Stocks International Value Diversifiers Stocks Top Silver Stocks Venezuela Oil Recovery (Energy & Services)Venezuela Seized Assets (Consumer/Industrial)

Cannabis - FAQ

Which Cannabis stocks have a "Strong Buy" analyst rating?

These Cannabis stocks currently have a "Strong Buy" analyst rating consensus:

Scotts Miracle-Gro Company - Strong Buy, based on 6 analyst ratings, 5 Buy, 1 Hold, and 0 Sell.

Jazz Pharmaceuticals - Strong Buy, based on 13 analyst ratings, 12 Buy, 1 Hold, and 0 Sell.

Curaleaf Holdings - Strong Buy, based on 5 analyst ratings, 5 Buy, 0 Hold, and 0 Sell.

Trulieve Cannabis - Strong Buy, based on 4 analyst ratings, 4 Buy, 0 Hold, and 0 Sell.

Are Cannabis stocks overpriced?

Canopy Growth's stock price is currently $1.15, and its average 12-month price target is $3.12.

Altria Group's stock price is currently $61.15, and its average 12-month price target is $66.25.

AbbVie's stock price is currently $214.04, and its average 12-month price target is $253.56.

Scotts Miracle-Gro Company's stock price is currently $62.80, and its average 12-month price target is $65.65.

Jazz Pharmaceuticals's stock price is currently $167.88, and its average 12-month price target is $219.54.

Curaleaf Holdings's stock price is currently $2.48, and its average 12-month price target is $3.77.

Green Thumb Industries's stock price is currently $7.81, and its average 12-month price target is $16.85.

Trulieve Cannabis's stock price is currently $8.08, and its average 12-month price target is $16.09.

's stock price is currently N/A, and its average 12-month price target is N/A.

Which Cannabis stocks pay dividends?

Canopy Growth does not currently pay dividends.

Altria Group does not currently pay dividends.

AbbVie does not currently pay dividends.

Scotts Miracle-Gro Company does not currently pay dividends.

Jazz Pharmaceuticals does not currently pay dividends.

Curaleaf Holdings does not currently pay dividends.

Green Thumb Industries does not currently pay dividends.

Trulieve Cannabis does not currently pay dividends.

does not currently pay dividends.